The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.Source: electronic medicines compendium (emc), DatapharmActive substance: carbocisteineOfficial document: view the original leaflet on emc →Medical disclaimer: This page is for information only and does not replace advice from your doctor or pharmacist. Always read the leaflet supplied with your medicine. If you are unwell, call NHS 111; in an emergency, call 999.

← Back to all medicines

Carbocisteine 750 mg hard capsules

⚠ This medicine appears to have been discontinued

The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.

If you were prescribed this medicine, other products containing Carbocisteine may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.

Active substance: Carbocisteine

Equivalent medicines (same active substance, strength and form)

→ Carbocisteine 750 mg Capsules, Hard

Source: electronic medicines compendium (emc)

Official leaflet: Read the PIL on emc

What you need to know before you take it

e Carbocisteine Capsule 3.How to take Carbocisteine Capsule 4.Possible side effects 5.How to store Carbocisteine Capsule 6.Contents of the pack and other information

Important information about some of the 1. WHAT CARBOCISTEINE CAPSULE IS AND ingredients of Carbocisteine Capsules WHAT IT IS USED FOR Carbocisteine Capsules contain: Carbocisteine 750 mg Capsules (called Carbocisteine

Lactose: This medicine contains lactose. This is a Capsules in this leaflet) contain a medicine called type of sugar. If you have been told by your doctor carbocisteine. This belongs to a group of that you cannot tolerate some sugars, talk to your medicines called 'mucolytics'. It works by making doctor before taking Carbocisteine Capsules. mucus (phlegm) less sticky. This makes the mucus
Sodium: This medicine contains less than 1 mmol easier to cough up. Carbocisteine Capsules are used sodium (23 mg) per capsule, that is to say for problems with the breathing passages essentially 'sodium free'. (respiratory tract). These problems happen when too much mucus is made or the mucus is too sticky.

How to take it

CARBOCISTEINE CAPSULE 2. WHAT YOU NEED TO KNOW BEFORE YOU Always take Carbocisteine Capsules exactly as your TAKE CARBOCISTEINE CAPSULE doctor has told you. You should check with your doctor or pharmacist if you are not sure. Do not take Carbocisteine capsules if:

Take this medicine by mouth
You are allergic to carbocisteine or any of the
If you feel that this medicine is too weak or too other ingredients of this medicine (listed in strong, do not change the dose yourself, but ask Section 6) your doctor
Signs of an allergic reaction include: a rash, swallowing or breathing problems, swelling of the Adults (including the elderly) lips, face, throat or tongue
Usual dose is one capsule, 3 times each day
You have an ulcer in your stomach or gut
If your symptoms improve, your dose should be lowered to one capsule, 2 times, each day Do not take this medicine if any of the above apply to you. If you are not sure, talk to your doctor or Children pharmacist before taking Carbocisteine Capsules.
Carbocisteine Capsules are not recommended for children. The normal daily dosage is 20mg/kg Warnings and precautions: body weight i doses. It is recn dividedommended Talk to your doctor or pharmacist before taking that this is achieved with carbocisteine paediatric Carbocisteine Capsules if: syrup.
You are elderly.
Have had an ulcer in your stomach or gut. If you take more Carbocisteine Capsules than
You are taking other medicines known to cause you should bleeding in the stomach. If you take more Carbocisteine Capsules than you should, tell a doctor or go to a hospital casualty Pregnancy and breast-feeding department straight away. Take the medicine pack Carbocisteine is not recommended during with you. This is so the doctor knows what you pregnancy or breast-feeding. have taken. If you take too many Carbocisteine Talk to your doctor before taking this medicine if: Capsules, it is likely that you will get an upset
You are pregnant, might become pregnant or think stomach (gastrointestinal disturbance). you may be pregnant. If you forget to take Carbocisteine Capsules
You are breast-feeding or planning to breast-feed. If you forget a dose, do not worry. Just wait until Ask your doctor or pharmacist for advice before the next dose is due. Do not take a double dose to taking any medicine if you are pregnant or breast-feeding. make up for a forgotten dose.

4. POSSIBLE SIDE EFFECTS Like all medicines, Carbocisteine Capsules can cause side effects, although not everybody gets them. Stop taking Carbocisteine Capsules and see a doctor or go to a hospital straight away if:

You have an allergic reaction. The signs may include: a rash, swallowing or breathing problems, swelling of the lips, face, throat or tongue
You have blistering or bleeding of the skin, including around your lips, eyes, mouth, nose and genitals. You may also have flu-like symptoms and fever. This may be something called 'Stevens-Johnson syndrome'
You have blood in your vomit or black tarry stools Tell your doctor or pharmacist if any of the following side effects get serious or lasts longer than a few days:
Feeling sick (nausea) or being sick (vomiting)
Diarrhoea
Stomach pain Talk to your doctor or pharmacist if you notice any side effects not listed in this leaflet.

What Carbocisteine Capsule looks like and contents of the pack Carbocisteine Capsules are size '00', dark yellow opaque cap and dark yellow opaque body unprinted Capsules. unprinted Capsules. They are available in blister packs containing 30, 60, 90 and 120 capsules. Not all pack sizes may be marked. Marketing Authorization Holder Flamingo Pharma (UK) Ltd. 1st Floor, Kirkland House, 11-15 Peterborough Road, Harrow, Middlesex, HA1 2AX, United Kingdom Manufacturer Flamingo Pharma (UK) Limited The Bloc, 38 Springfield Way, Anlaby, Hull, HU10 6RJ, United Kingdom This leaflet does not contain all the information about your medicine. If you have any questions or are not sure about anything, ask your doctor or pharmacist. This leaflet was last revised in 03/2025.

Other sources of information To request a copy of this leaflet in Braille, large print or audio please call free of charge: 0800 198 5000 (UK only). Please be ready to give the following information: Product Name: Carbocisteine 750 mg Hard Capsules Reference

Possible side effects

not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

Do not use this medicine after the expiry date which is stated on the carton after "EXP". The expiry date refers to the last day of that month. Do not store above 30°C. Store in the original package. Do not throw away any medicines via waste water or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

How to store it

CARBOCISTEINE CAPSULE Number: PL 43461/0107 This is a service provided by the Royal Keep this medicine out of the sight and reach of children. National Institute of Blind People. Reporting of side effects If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible

Contents of the pack and other information

What Carbocisteine Capsules contain

Each gelatin capsule contains 750mg of the active substance, carbocisteine
The other ingredients are colloidal anhydrous silica, lactose monohydrate, magnesium stearate. Capsule shell contains gelatin, sodium laurilsulfate, iron oxide yellow (E172) and titanium dioxide (E171).

POM PL 43461/0107

MPLLCAR0750CP0 60FPLXXX366V01_B

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

Keep this leaflet. You may need to read it again.
If you have any further questions, ask your doctor or pharmacist.
This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

carbocisteine

Carbocisteine 750 mg Hard Capsules

PACKAGE LEAFLET: INFORMATION FOR THE USER

Frequently asked questions about Carbocisteine 750 mg hard capsules

How do I take Carbocisteine 750 mg hard capsules?

Carbocisteine 750 mg hard capsules comes as capsule containing 750mg. Always follow the dose your doctor or pharmacist has given you, and read the leaflet that comes with the medicine.

What is the active substance in Carbocisteine 750 mg hard capsules?

The active substance in Carbocisteine 750 mg hard capsules is carbocisteine.

Are there equivalent medicines to Carbocisteine 750 mg hard capsules?

Medicines with the same active substance, strength and form include: Carbocisteine 750 mg Capsules, Hard. They are interchangeable only if your prescriber or pharmacist says so.

Where does this information come from?

This leaflet reproduces the patient information leaflet approved for Carbocisteine 750 mg hard capsules, as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.

Can I get Carbocisteine 750 mg hard capsules without a prescription?

Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.

About this leaflet

The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.

Source: electronic medicines compendium (emc), Datapharm
Active substance: carbocisteine
Official document: view the original leaflet on emc →

Medical disclaimer: This page is for information only and does not replace advice from your doctor or pharmacist. Always read the leaflet supplied with your medicine. If you are unwell, call NHS 111; in an emergency, call 999.

Medicines with the same active substance: Carbocisteine (12 medicines)

See every medicine containing this substance, or browse the full A–Z of active substances.

⚕For healthcare professionals — Summary of Product Characteristics (SmPC)Full SmPC: dosage, interactions, contraindications, warnings+

Technical information intended for healthcare professionals (doctors and pharmacists). The Summary of Product Characteristics (SmPC) is the official document approved by the MHRA/EMA. It does not replace the patient leaflet or a doctor’s advice.

4.1. Therapeutic indications

Carbocisteine is a mucolytic agent for the adjunctive therapy of respiratory tract disorders characterized by excessive, viscous mucus, including chronic obstructive airways disease.

4.2. Posology and method of administration

Adults including the elderly:

Dosage is based upon an initial daily dosage of 2250 mg Carbocisteine in divided doses, reducing to 1500 mg daily in divided doses when a satisfactory response is obtained e.g. one capsule three times a day reducing to one capsule two times a day.

Paediatric population:

This formulation is not recommended for children. The normal daily dosage is 20 mg/kg body weight in divided doses. It is recommended that this is achieved with carbocisteine paediatric syrup.

Method of administration

Carbocisteine capsules are for oral use.

4.3. Contraindications

• Hypersensitivity to the active substance(s) or to any of the excipients listed in section 6.1.

• Use in patients with active peptic ulceration.

4.4. Special warnings and precautions for use

Caution is recommended in the elderly, in those with a history of gastroduodenal ulcers, or those taking concomitant medications known to cause gastrointestinal bleeding. If gastrointestinal bleeding occurs, patients should discontinue medication. Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine.

4.5. Interaction with other medicinal products and other forms of interaction

None stated.

4.6. Fertility, pregnancy and lactation

Pregnancy

There are no available data on carbocisteine use in pregnant women. No conclusions can be drawn regarding whether or not carbocisteine is safe for use during pregnancy. The use of carbocisteine in pregnant women is not recommended, especially during the first trimester.

Breast-feeding

There are no available data on the presence of carbocisteine in human milk, milk production, or the effects on the breastfed infant. No conclusions can be drawn regarding whether or not carbocisteine is safe for use during breastfeeding. The use of carbocisteine in breastfeeding women is not recommended.

Fertility

There is no consistent evidence on the effects of this product on fertility in males or females.

4.7. Effects on ability to drive and use machines

Carbocisteine has no or negligible influence on the ability to drive and use machines.

4.8. Undesirable effects

The following CIOMS frequency rating is used, when applicable: Very common (≥1/10); common (≥1/100 to <1/10); uncommon (≥1/1,000 to ≤1/100); rare (≥1/10,000 to ≤1/1,000); very rare (≤1/10,000); not known (cannot be estimated from the available data).

Immune System Disorders

There have been reports of anaphylactic reactions, allergic skin eruption and fixed drug eruption.

Gastrointestinal disorders

There have been reports of diarrhoea, nausea, epigastric discomfort and gastrointestinal bleeding occurring during treatment with this carbocisteine. Frequency not known: vomiting, gastrointestinal bleeding

Skin and Subcutaneous Tissue Disorders

There have been reports of skin rashes and allergic skin eruptions. Isolated cases of bullous dermatitis such as Stevens–Johnson syndrome and erythema multiforme have also been reported.

Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

4.9. Overdose

Gastric lavage may be beneficial, followed by observation. Gastrointestinal disturbance is the most likely symptom of Carbocisteine overdose.

💬 Ask about this leaflet

Ask anything about Carbocisteine 750 mg hard capsules. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.

Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.

Pharmacy Guide